Getting pharmaceuticals to the right patient at the right time is a complex task, at best. This is even more daunting in the face of a natural disaster, where roads and other routes transport may be unreliable, unavailable, or even unsafe. Full Article »

Coding, serialisation and traceability/track & trace are proposed as solutions by governments and technology providers but un-coordinated and conflicting coding requirements, competing technologies, scope and timescale challenges, standards that are not yet fully emerged and conflicts between data integrity, security, packaging performance all add to the challenge for the industry. Full Video »

Ahead of the Pharmaceutical Distribution Conference in Amsterdam, Niamh Madigan interviews Hubert Koevoets, Director Distribution Europe & Transactional Management from Celgene to discover the trials and tribulations of logistics in the pharma industry. Full Podcast »

Insurance is critical for the safe delivery of your products. Mark Edwards, Global Freight Manager at Actavis, shares tips on pitfalls to avoid and speaks of his own experience which shows why it must be a priority for any organisation. Full Column »

Why do we actually need to monitor Biobanking Facilities? There are several reasons for that: You have to ensure the sample integrity and to document the storage conditions. Another point is the required compliance with national and international regulations e.g. FDA Good Tissue Practice (GTP), FDA Good Storage Practice (GSP). Furthermore a monitoring allows you an early detection of trends in environmental conditions and to respond proactively and to raise alarms and warnings in case of adverse events e.g. temperature deviation. Full Whitepaper »